Full text
Earnings transcript
Read the complete earnings call transcript.
WELL
Welltower Inc.
$244.88
1.63
(0.67%)
| Exchange: | NYSE |
| Market Cap: | 172.864B |
| Shares Outstanding: | 4.207M |
Delayed data
About The Company
| Sector: | Real Estate | |||||
| Industry: | REIT – Healthcare Facilities | |||||
| CEO: | Shankh S. Mitra | |||||
| Full Time Employees: | 712 | |||||
| Address: |
| |||||
| Website: | https://www.welltower.com |
Welltower Inc. (NYSE:WELL), an S&P 500 company based in Toledo, Ohio, is a leader in reshaping healthcare infrastructure. This Real Estate Investment Trust (REIT) strategically collaborates with premier operators in seniors housing, post-acute care, and health systems. Their core mission is to finance the vital property assets required to expand innovative care delivery models, thereby enhancing overall public wellness and healthcare experiences. Welltower’s portfolio encompasses a variety of properties, including seniors housing, post-acute communities, and outpatient medical facilities, all situated primarily within key, rapidly growing markets across the United States, Canada, and the United Kingdom.
Click to read more…
Revenue Segmentation
EPS
Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.
Earnings Call
AI summary
Key takeaways
Short, structured highlights from the call so you can focus on what matters.
Log in to continue
Log in to read the full transcript and AI-generated earnings summaries.
Login — it's freeIncome Statement
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 6,478,231 | 7,853,618 | 10,667,136 |
| Gross Profit | 2,530,455 | 3,023,407 | 4,179,055 |
| EBITDA | 2,401,110 | 2,778,336 | 2,310,458 |
| Operating Income | 940,454 | 1,145,698 | 355,168 |
| Net Income | 340,094 | 951,680 | 936,845 |
(* All numbers are in thousands)
Balance Sheet
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total Assets | 44,012,166 | 51,044,308 | 67,303,047 |
| Total Liabilities | 17,640,439 | 18,471,722 | 24,100,108 |
| Total Stockholders Equity | 25,404,376 | 31,956,208 | 42,129,498 |
| Total Debt | 16,118,779 | 16,758,356 | 2,813,780 |
| Cash and Cash Equivalents | 1,993,646 | 3,506,586 | 5,033,678 |
(* All numbers are in thousands)
Cash Flow Statement
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating Cash Flow | 1,601,861 | 2,256,421 | 2,881,677 |
| Capital Expenditure | -50,699 | -58,115 | 0 |
| Free Cash Flow | 1,551,162 | 2,198,306 | 2,881,677 |
| Net Income | 340,094 | 972,857 | 117,767 |
| Net Change in Cash | 1,353,791 | 1,635,374 | 1,498,082 |
(* All numbers are in thousands)
Analyst Estimates
| Fiscal Year | 2029 | Research Access | Research Access | Research Access | Research Access |
|---|---|---|---|---|---|
| Estimated Revenue (Low) | 15,910,900.383 | Research Access | Research Access | Research Access | Research Access |
| Estimated Revenue (High) | 17,774,303.318 | Research Access | Research Access | Research Access | Research Access |
| Estimated Revenue (Avg) | 16,705,800 | Research Access | Research Access | Research Access | Research Access |
| Estimated Ebitda (Low) | 5,276,045.619 | Research Access | Research Access | Research Access | Research Access |
| Estimated Ebitda (High) | 5,893,948.985 | Research Access | Research Access | Research Access | Research Access |
| Estimated Ebitda (Avg) | 5,539,633.885 | Research Access | Research Access | Research Access | Research Access |
| Estimated Net Income (Low) | 3,314,934.480 | Research Access | Research Access | Research Access | Research Access |
| Estimated Net Income (High) | 3,827,313.700 | Research Access | Research Access | Research Access | Research Access |
| Estimated Net Income (Avg) | 3,533,509.205 | Research Access | Research Access | Research Access | Research Access |
| Estimated SGA Expense (Low) | 873,458.480 | Research Access | Research Access | Research Access | Research Access |
| Estimated SGA Expense (High) | 975,753.451 | Research Access | Research Access | Research Access | Research Access |
| Estimated SGA Expense (Avg) | 917,095.974 | Research Access | Research Access | Research Access | Research Access |
| Estimated EPS (Avg) | 5.200 | Research Access | Research Access | Research Access | Research Access |
| Estimated EPS (High) | 5.630 | Research Access | Research Access | Research Access | Research Access |
| Estimated EPS (Low) | 4.880 | Research Access | Research Access | Research Access | Research Access |
| Number of Analysts (Estimated Revenue) | 5 | Research Access | Research Access | Research Access | Research Access |
| Number of Analysts (Estimated EPS) | 4 | Research Access | Research Access | Research Access | Research Access |
Log in to continue
Log in and subscribe to Full Access to see up to 5 years of analyst estimates.
Login — it's free(* All numbers are in thousands)
Current Key Metrics
Log in to continue
Log in to see all key valuation metrics and ratios for this symbol.
Login — it's freeForward P/E Ratios
Log in to continue
Log in with Full Access for forward P/E high/low estimates and the full multi-year table.
Login — it's freeSWOT Analysis
Strengths (preview)
- Record Financial Performance: Welltower reported a record quarter in Q3 2025, as highlighted in the earnings call transcript, with strong occupancy rates and revenue growth. Key financial results exceeded expectations, reflecting robust operational efficiency and market demand in the senior housing and healthcare real estate sectors.
- Solid Profitability Metrics: Based on key metrics (TTM), Welltower demonstrates healthy profitability with competitive gross profit margin and net profit margin figures, indicating effective cost management and revenue generation compared to industry peers in the healthcare REIT sector.
- Positive Industry Positioning: Performance data shows Welltower outperforming industry averages over multiple timeframes (1-year and 5-year periods), supported by sectorName and industryName data, suggesting a strong competitive position within the healthcare real estate market.
Log in with Research Access for Weaknesses, Opportunities, Threats, and the complete SWOT.
At what price to buy it? -
Intrinsic Value Calculator
Based on current fundamentals and analyst forecasts, MARKETSnap estimates WELL intrinsic value between $53.14 – $187.46 per share. This depends on revenue growth, margins, and discount rate.
This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.
[intrinsic_calculator]
Common questions about WELL valuation
Is Welltower Inc. (WELL) overvalued or undervalued right now?
MARKETSnap estimates intrinsic value for Welltower Inc. (WELL) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.
Is WELL a buy, hold, or sell for long-term investors?
MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether WELL trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.
What is WELL’s P/E ratio?
You can see WELL’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.
How is intrinsic value calculated for WELL?
MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.
Is WELL a good long-term investment?
Whether WELL fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.
WELL
1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.
Daily snapshot
0.67
Trading Metrics:
| Open: | 244.09 | Previous Close: | 243.25 | |
| Day Low: | 242.68 | Day High: | 245.36 | |
| Year Low: | 158.24 | Year High: | 246.43 | |
| Price Avg 50: | 218.38 | Price Avg 200: | 200.58 | |
| Volume: | 1.887M | Average Volume: | 3.475M |
Log in to continue
Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.
Login — it's freeWELL full analysis
Hey everyone, welcome back to the channel! Today, we’re diving deep into a comprehensive analysis of Welltower Inc., ticker symbol WELL, a major player in the healthcare real estate space. If you’re looking to invest in a company tied to the growing demand for senior housing and medical facilities, stick around because I’ve got a ton of insights to share. Let’s break down everything from their financials to their market position and see if this stock is a buy for…
